Evaluation of a homoeopathic therapeutic strategy involving tuberculinum, zincum metallicum, Chininum arsenicosum and calcarea phos in prophylaxis of COVID-19

Abstract

Background: In March 2020, WHO declared the COVID-19 outbreak as a pandemic. Preventive strategies have been explored by a large number of researchers. Zincum Metallicum and China Ars are known to prevent replication of the virus. A use of nosodes Tuberculinum enhances the action of these components used in the formulation.Methods: The study is an open-label randomized controlled trial evaluating the immune boosting ability of a Homoeopathic therapeutic strategy involving a nosodes Tuberculinum 1M, followed by Zincum Metallicum 6c, Chininum arsenicosum 6c and Calcarea Phos 6x in asymptomatic Novel coronavirus disease (COVID-19 ) in vulnerable risk group.Results: A statistically significant effect was observed in the strata of age group of 21-30 in terms of completion of treatment (p< 0.001). Among the occupation, the health professionals group showed statistically significant results with respect to completion of the treatment (p